Breast cancer patients in mozambique get a guide: study tests if navigation speeds up treatment
NCT ID NCT06257888
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looked at whether patient navigators can help women with breast cancer in Mozambique start treatment sooner. Ninety women received support from trained navigators from admission to their first treatment. Researchers measured time delays and survival rates compared to past patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- patient navigation
- What this could lead to
- If successful, this could show that patient navigation reduces delays in breast cancer treatment and improves survival in low-resource settings.
- What could go wrong
- This is an observational study with a small group of 90 women and no control group, so results may not be generalizable. The intervention is support-based, not a medical treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM MALIGNANT PRIMARY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Central de Maputo
Maputo, Cidade de Maputo, 010103, Mozambique
More trials for these conditions
Other studies related to the condition(s) this trial covers.